The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Regulatory News (AV.)

Share Price Information for Aviva (AV.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.10
Bid: 489.10
Ask: 489.20
Change: 5.20 (1.08%)
Spread: 0.10 (0.02%)
Open: 477.10
High: 490.20
Low: 475.40
Prev. Close: 482.90
AV. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of a noteholders’ meeting

14 Jul 2023 12:12

RNS Number : 1026G
Aviva PLC
14 July 2023
 

FOR DISTRIBUTION ONLY OUTSIDE THE UNITED STATES TO PERSONS OTHER THAN "U.S. PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH, OR DISTRIBUTE THIS DOCUMENT.

AVIVA plc (incorporated in England with limited liability, registered number 2468686) announces results of a noteholders' meeting in respect of its outstanding£600,000,000 Tier 2 Fixed to Floating Rate Notes due 2058 (ISIN: XS0364880186)(the "Notes")

On 22 June 2023, Aviva plc (the "Issuer") announced an invitation (the "Consent Solicitation") to eligible holders of its outstanding Notes to consent to the modification of the terms and conditions (the "Conditions") of the Notes and the final terms which complete such Conditions (the "Final Terms") and consequential or related amendments to the transaction documents for the Notes such that the Notes:

(i) continue to be recognised and valued as Tier 2 basic own funds of the Issuer under applicable law, regulation and guidance following the end of the Solvency II transition period on 31 December 2025; and

(ii) closer align commercially and technically with the terms and conditions of Tier 2 notes currently set out in the Issuer's £7,000,000,000 Euro Note Programme, which are broadly consistent with the terms and conditions of other similar securities in the market in this regard.

A meeting (the "Meeting") of the holders of the Notes (the "Noteholders") was held via teleconference earlier today, 14 July 2023, in connection with the Consent Solicitation, and the Issuer now announces the results of the Meeting.

This announcement does not contain the full terms and conditions of the Consent Solicitation, which are contained in the Consent Solicitation Memorandum dated 22 June 2023 (the "Consent Solicitation Memorandum") prepared by the Issuer, which is available to Eligible Noteholders (as defined therein) from the Tabulation Agent (including on its website via the link https://deals.is.kroll.com/aviva).

Unless otherwise indicated, capitalised terms used but not otherwise defined in this announcement have the meanings given in the Consent Solicitation Memorandum.

Details of the Notes

 

Notes

ISIN / Common Code

Prevailing interest rate (per annum)

First Call Date and Fixed Rate End Date

Maturity Date*

Outstanding principal amount

Voting Fee

2038/2058 Notes

XS0364880186 / 036488018

6.875 per cent.

20 May 2038

May 2058

£600,000,000

16 per cent.**

* The Maturity Date for the Notes is the Interest Payment Date falling in or nearest to the specified month.

** Ineligible Noteholders who submitted Ineligible Holder Instructions, which were received by the Tabulation Agent on or before the Expiration Deadline, may be eligible to receive an equivalent amount to the Voting Fee (such amount referenced herein as the Ineligible Holder Payment).

Results of the Meeting

NOTICE IS HEREBY GIVEN to the Noteholders that:

(a) at the Meeting, the necessary quorum was achieved, the Extraordinary Resolution was passed and the Eligibility Condition was satisfied;

(b) the Supplemental Trust Deed has been executed and delivered by the Issuer and the Trustee, and the Amended and Restated Final Terms have been executed by the Issuer, today, 14 July 2023; and

(c) the modifications to the Conditions and Final Terms of, and the transaction documents for, the Notes described in the Consent Solicitation Memorandum have been implemented with effect from today, 14 July 2023.

Voting Fee and Ineligible Holder Payment

 

As the Extraordinary Resolution has been passed, the other relevant Consent Conditions have been satisfied and the Proposed Amendments have been implemented, the Voting Fee is payable to those Eligible Noteholders who submitted (and did not revoke) valid Consent Instructions (whether in favour of or against the Extraordinary Resolution), which were received by the Tabulation Agent on or before the Expiration Deadline. Ineligible Noteholders who submitted (and did not revoke) Ineligible Holder Instructions, which were received by the Tabulation Agent on or before the Expiration Deadline, are eligible to receive an equivalent amount to the Voting Fee (such amount referenced herein as the Ineligible Holder Payment). The Payment Date in respect of: (i) the Voting Fee payable to the relevant Eligible Noteholders, and (ii) the Ineligible Holder Payment payable to the relevant Ineligible Noteholders will be no later than the fifth Business Day following the Implementation Date (currently expected to be on 21 July 2023).

 

Further details on the Consent Solicitation can be obtained from:

SOLICITATION AGENT

Lloyds Bank Corporate Markets plc

10 Gresham Street

London EC2V 7AE

United Kingdom

Attention: Liability Management Group

Tel: +44 20 7158 1719 / 1726

Email: LBCMLiabilityManagement@lloydsbanking.com

Requests for documentation and information in relation to the procedures for delivering Consent Instructions should be directed to:

TABULATION AGENT

Kroll Issuer Services Limited

The Shard

32 London Bridge Street

London SE1 9SG

United Kingdom

Attention: David Shilson/Jacek Kusion

Tel: +44 20 7704 0880

Email: aviva@is.kroll.com

Website: https://deals.is.kroll.com/aviva

 

DISCLAIMER

Nothing in this announcement or the Consent Solicitation Memorandum constitutes or contemplates an offer of, an offer to purchase or the solicitation of an offer to sell securities in the United States or any other jurisdiction. The Notes have not been, and will not be, registered under the Securities Act, or the securities laws of any state or other jurisdiction of the United States, and the Notes may not be offered, sold or delivered, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities laws.

UK MiFIR professionals/ECPs-only / No EEA or UK PRIIPs KID - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EEA or UK PRIIPs key information document (KID) has been prepared.

The distribution of this announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law, and persons into whose possession this announcement or the Consent Solicitation Memorandum comes are requested to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFSFFLEDSEFW
Date   Source Headline
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20242:43 pmRNSForm 8.3 - Tritax Big Box REIT plc
3rd Apr 20242:42 pmRNSForm 8.3 - Spirent Communications plc
3rd Apr 20242:40 pmRNSForm 8.3 - Smith (DS) plc
3rd Apr 20242:39 pmRNSForm 8.3 - Mondi plc
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202411:43 amRNSTotal Voting Rights
2nd Apr 202411:37 amRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20242:23 pmRNSForm 8.3 - International Paper Company
28th Mar 202410:00 amRNSNotice of AGM
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 202410:15 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20244:50 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20242:14 pmRNSForm 8.3 - Smith (DS) plc
21st Mar 202410:00 amRNSReplacement - Director/PDMR Shareholding
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 202410:45 amRNSHolding(s) in Company
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20243:22 pmRNSForm 8.3 - Tritax Big Box REIT plc
19th Mar 20243:20 pmRNSForm 8.3 - Smith (DS) plc
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20242:39 pmRNSForm 8.3 - UK Commercial Property REIT LTD
18th Mar 20242:37 pmRNSForm 8.3 - Tritax Big Box REIT PLC
18th Mar 20242:33 pmRNSForm 8.3 - Mondi plc
18th Mar 20247:00 amRNSAviva completes exit of Singlife joint venture
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 202411:17 amRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20242:30 pmRNSForm 8.3 - Mondi PLC
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20243:10 pmRNSForm 8.3 - Smith (DS) plc
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 202410:00 amRNSDirectorate Change
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20242:32 pmRNSForm 8.3 - Mondi PLC
11th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20244:10 pmRNSDividend Declaration
7th Mar 20243:32 pmRNSHolding(s) in Company
7th Mar 202412:26 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSAviva plc 2023 Results Announcement
6th Mar 20242:34 pmRNSForm 8.3 - Mondi PLC
6th Mar 20242:31 pmRNSForm 8.3 - Spirent Communications PLC
5th Mar 20242:40 pmRNSForm 8.3 - Mondi plc
4th Mar 20247:00 amRNSAcquisition of Probitas
1st Mar 20242:22 pmRNSForm 8.3 - Mondi PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.